![]()
|
|
||||||||
J. Biol. Chem., Vol. 259, Issue 16, 10175-10180, Aug, 1984
RA Schmidt, CJ Schneider and JA Glomset
Previous studies have identified several cellular requirements for
mevalonic acid that appear unrelated to cholesterol, dolichol, or
ubiquinone. To search for other products of mevalonic acid that might
account for these requirements we cultured Swiss 3T3 cells in the presence
of mevinolin, an inhibitor of mevalonic acid biosynthesis, then labeled the
cells with exogenous radioactive mevalonic acid. Upon analyzing the
radioactive material formed, we found that 40-50% of it was not extractable
into lipid solvents, and that most of the lipid- insoluble material behaved
like protein when treated with sodium dodecyl sulfate:chloroform:phenol,
RNase, or proteinase K. Further analysis by electrophoresis revealed that
radioactivity was associated with a few specific proteins that had apparent
molecular weights of 13,000-58,000. Control experiments indicated that
authentic radioactive (R)-mevalonic acid was the active precursor. Other
lines of evidence suggested that mevalonate was first converted to an
isoprenoid compound, then covalently incorporated into proteins by way of a
cycloheximide-insensitive mechanism. These results suggest that Swiss 3T3
cells possess novel metabolic products of mevalonic acid metabolism that
are formed by post-translational incorporation of isoprenoids into specific
cell proteins.
Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Fukunaga, M. Arita, M. Takahashi, A. J. Morris, M. Pfeffer, and B. D. Levy Identification and Functional Characterization of a Presqualene Diphosphate Phosphatase J. Biol. Chem., April 7, 2006; 281(14): 9490 - 9497. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Young, L. G. Fong, and S. Michaelis Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria--new evidence suggesting that protein farnesylation could be important for disease pathogenesis J. Lipid Res., December 1, 2005; 46(12): 2531 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Duncan, A. El-Sohemy, and M. C. Archer Mevalonate Promotes the Growth of Tumors Derived from Human Cancer Cells in Vivo and Stimulates Proliferation in Vitro with Enhanced Cyclin-dependent Kinase-2 Activity J. Biol. Chem., August 6, 2004; 279(32): 33079 - 33084. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mo and C. E. Elson Studies of the Isoprenoid-Mediated Inhibition of Mevalonate Synthesis Applied to Cancer Chemotherapy and Chemoprevention Experimental Biology and Medicine, July 1, 2004; 229(7): 567 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Clase, M. G. Lyman, T. del Rio, J. A. Randall, C. M. Calton, L. W. Enquist, and B. W. Banfield The Pseudorabies Virus Us2 Protein, a Virion Tegument Component, Is Prenylated in Infected Cells J. Virol., November 15, 2003; 77(22): 12285 - 12298. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Baron, E. Fourcade, I. Lajoie-Mazenc, C. Allal, B. Couderc, R. Barbaras, G. Favre, J.-C. Faye, and A. Pradines RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: Evidenced in vivo by an anti-farnesyl cysteine antibody PNAS, October 10, 2000; 97(21): 11626 - 11631. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Parmryd, B. Andersson, and G. Dallner Protein prenylation in spinach chloroplasts PNAS, August 31, 1999; 96(18): 10074 - 10079. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuzuguchi, Y. Morita, I. Sagami, H. Sagami, and K. Ogura Human Geranylgeranyl Diphosphate Synthase. cDNA CLONING AND EXPRESSION J. Biol. Chem., February 26, 1999; 274(9): 5888 - 5894. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Laezza, V. Di Marzo, and M. Bifulco v-K-ras leads to preferential farnesylation of p21ras in FRTL-5 cells: Multiple interference with the isoprenoid pathway PNAS, November 10, 1998; 95(23): 13646 - 13651. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Otto and P. J. Casey The Hepatitis Delta Virus Large Antigen Is Farnesylated Both in Vitro and in Animal Cells J. Biol. Chem., March 1, 1996; 271(9): 4569 - 4572. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hohl and K. Lewis Differential Effects of Monoterpenes and Lovastatin on RAS Processing J. Biol. Chem., July 21, 1995; 270(29): 17508 - 17512. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Perillo, I. Tedesco, C. Laezza, M. Santillo, A. Romano, S. M. Aloj, and M. Bifulco Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Gene Expression in FRTL-5 Cells J. Biol. Chem., June 23, 1995; 270(25): 15237 - 15241. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Sinensky, T McLain, and K Fantle Expression of prelamin A but not mature lamin A confers sensitivity of DNA biosynthesis to lovastatin on F9 teratocarcinoma cells J. Cell Sci., January 8, 1994; 107(8): 2215 - 2218. [Abstract] [PDF] |
||||
![]() |
O. Larsson and J. Wejde Dolichol delays G1-arrest for one cell cycle in human fibroblasts subjected to depletion of serum or mevalonate J. Cell Sci., December 1, 1992; 103(4): 1065 - 1072. [Abstract] [PDF] |
||||
![]() |
H. Rilling, E Breunger, W. Epstein, and P. Crain Prenylated proteins: the structure of the isoprenoid group Science, January 19, 1990; 247(4940): 318 - 320. [Abstract] [PDF] |
||||
![]() |
C. Farnsworth, M. Gelb, and J. Glomset Identification of geranylgeranyl-modified proteins in HeLa cells Science, January 19, 1990; 247(4940): 320 - 322. [Abstract] [PDF] |
||||
![]() |
W. Schafer, R Kim, R Sterne, J Thorner, S. Kim, and J Rine Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans Science, July 28, 1989; 245(4916): 379 - 385. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |